Annual report pursuant to Section 13 and 15(d)

ASSET ACQUISITION (Details)

v3.24.1
ASSET ACQUISITION (Details)
$ in Millions
Jan. 12, 2022
USD ($)
Vyne product acquisition  
Asset Acquisition  
Upfront payment $ 20.0
Additional payment $ 5.0
Percentage of upfront payment received 10.00%
Vyne product acquisition | If annual sales reaches to $100 million  
Asset Acquisition  
Annual sales $ 100.0
One-time payment 10.0
Vyne product acquisition | If annual sales reaches to $200 million  
Asset Acquisition  
Annual sales 200.0
One-time payment $ 20.0
Minocycline products  
Asset Acquisition  
Business Acquisition interest 4.00%
Molecule Stabilizing Technology  
Asset Acquisition  
Business Acquisition interest 1.50%